Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy

Q: How does OCRA curate its research paper database?

OCRA indexes peer-reviewed papers from PubMed and CrossRef, enriched with MeSH terms, author profiles, and citation metrics. Papers are categorized by cancer type, research method, and clinical relevance.

Q: Can I search papers by MeSH term or author?

Yes. Use the search bar to filter papers by MeSH term, author name, journal, keyword, or cancer type. Each paper includes linked MeSH terms and author profiles for further exploration.

Q: How current is the paper database?

The database is updated regularly through automated ingestion from PubMed and CrossRef. Most papers appear within days of their PubMed indexing date.

Thomas Scattolin; Giovanni Tonon; Simona Kranjc Brezar; Maria Dalla Pozza; Vincenzo Canzonieri; Nicola Demitri; Steven P. Nolan; Gilles Gasser; Fabiano Visentin; Flavio Rizzolio

doi:10.1039/d5dt00194c

Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy

Thomas Scattolin & Flavio Rizzolio et al. · 2025-03-11

High-Grade Serous Ovarian Cancer (HGSOC) is the most common and lethal subtype of ovarian cancer, known for its high aggressiveness and extensive genomic alterations.

Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy

Links

Journal

Institutions

Authors

Funding